Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds

NCT05607979 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Lavior Pharma Inc.